The Net Clinical Benefit of Rivaroxaban Compared to Low-Molecular-Weight Heparin in the Treatment of Cancer-Associated Thrombosis: Systematic Review and Meta-Analysis

por Mohamed, Mouhand F. H., ElShafei, Mohamad Nabil, Ahmed, Mohamed Badie, Abdalla, Lina O., Ahmed, Israa, Elzouki, Abdel-Naser, Danjuma, Mohammed ibn-mas’ud
Publicado 2021

Comparative effectiveness and safety of direct-acting oral anticoagulants (DOACS) for the reduction of recurrent venous thromboembolism in cancer patients: A protocol for systemati...

por Danjuma, Mohammed ibn-Mas’ud, Mohamed, Mouhand F.H., ElShafei, Mohamad Nabil, Fatima, Haajra, Shokri, Shaikha Al, Mohamed, Sara, Abubeker, Ibrahim Yusuf, Kartha, Anand, Elzouki, Abdel-Naser, Mohamedali, Mohamed Gaafar Hussein, Mahgboub, Yahya, Bidmos, Mubarak
Publicado 2020